Massivemarkets

SEC Form 4

Merck & Co., Inc. (MRK) insider trading

In the 12 months to Oct 24, 2026, 11 MRK insiders reported open-market sales of $72.0M across 21 filings; no open-market purchases were filed.

Latest filing · Last 12 months · Source: SEC EDGAR · How we count

Open-market sales
$72.0M
21 filings · 11 insiders
Open-market purchases
$0
0 filings

Who traded MRK, and when

  • Sale

MRK daily close from Oct 24, 2025 to Oct 23, 2026, between $82.49 and $156.45, last $145.27. 21 sale and 0 purchase filings by 11 insiders, marked at their filing dates. Jennifer Zachary, EVP, General Counsel: sold $25.2M across 2 filings, first filed Feb 9, 2026, last Aug 13, 2026. Richard R. DeLuca, EVP&Pres, Merck Animal Heallth: sold $11.3M across 3 filings, first filed Feb 6, 2026, last Aug 12, 2026. Chirfi Guindo, Chief Marketing Officer → EVP, Access, Policy & Comms: sold $8.2M across 5 filings, first filed Feb 6, 2026, last Aug 13, 2026. David Michael Williams, EVP,Chief Info&Digital Officer: sold $8.1M across 3 filings, first filed Nov 4, 2025, last Aug 7, 2026. Robert M. Davis, Chairman, CEO & President: sold $5.6M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. Caroline Litchfield, EVP & CFO: sold $5.0M across 1 filing, first filed Feb 6, 2026, last Feb 6, 2026. 5 others: sold $8.6M across 6 filings, first filed Nov 12, 2025, last Aug 7, 2026.

Largest mark · tap a row for others

Jennifer Zachary · EVP, General Counsel

Sale $14,485,690

121,573 shares at $119.15 avg

Filed Feb 9, 2026

Close on filing date $117.65

MRK daily closelast $145.27

Jennifer Zachary · EVP, General Counsel

$25.2M sold

Richard R. DeLuca · EVP&Pres, Merck Animal Heallth

$11.3M sold

Chirfi Guindo · Chief Marketing Officer → EVP, Access, Policy & Comms

$8.2M sold

David Michael Williams · EVP,Chief Info&Digital Officer

$8.1M sold

Robert M. Davis · Chairman, CEO & President

$5.6M sold

Caroline Litchfield · EVP & CFO

$5.0M sold

5 others

$8.6M sold
One row per insider, smaller filers combined; marks sit at the SEC filing date, sized by dollar value.

Has Merck & Co., Inc.'s CEO sold stock?

Yes. Robert M. Davis (CEO) sold 47,434 shares ($5.6M) in Feb 2026.

Open-market trades

21 filings in the last 12 months
InsiderRoleSoldBoughtFilingsPre-arranged (10b5-1)Last filed
Jennifer ZacharyEVP, General Counsel$25.2M—2—
Richard R. DeLucaEVP&Pres, Merck Animal Heallth$11.3M—3—
Chirfi GuindoChief Marketing Officer → EVP, Access, Policy & Comms$8.2M—5—
David Michael WilliamsEVP,Chief Info&Digital Officer$8.1M—3—
Robert M. DavisChairman, CEO & President$5.6M—1—
Caroline LitchfieldEVP & CFO$5.0M—1—
Dean Y. LiExecutive VP & President, MRL$3.0M—2—
David R. MaraldoEVP & Pres. MMD$2.4M—1—
Johannes Jacobus OosthuizenPresident, U.S. Market$1.8M—1—
Dalton E. Smart IIISVP Fin. - Global Controller$765.9K—1—
Cristal N. DowningChief Comm. & Public Afrs Ofcr$616.4K—1—
Other insider activity (not market trades) · 56 records
  • Option exercises30 records
  • Tax withholding15 records
  • Grants and awards11 records

Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.

Build this yourself

This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:

Agent prompt

Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MRK every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.

How to read this page

Open-market purchase or sale
A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
Role
The title on each filing. Someone whose title changed shows more than one.
Filing date
Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.